Colon Polyps |
Colonic Polyps; What I need to know about Colon Polyps |
Clinical Trial: Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
This study is currently recruiting patients.
Purpose
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as bevacizumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Bevacizumab may also stop the growth of tumor cells by stopping blood flow to the tumor. Giving chemotherapy together with bevacizumab may kill more tumor cells. It is not yet known whether treatment with oxaliplatin, leucovorin, and fluorouracil is more effective with or without bevacizumab in treating patients who have undergone surgery for colon cancer.
PURPOSE: This randomized phase III trial is studying giving oxaliplatin, leucovorin, and fluorouracil together with bevacizumab to see how well it works compared to oxaliplatin, leucovorin, and fluorouracil alone in treating patients who have undergone surgery for stage II or stage III colon cancer.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| adenocarcinoma of the colon stage II colon cancer stage III colon cancer | Drug: bevacizumab Drug: fluorouracil Drug: leucovorin calcium Drug: oxaliplatin Procedure: adjuvant therapy Procedure: anti-cytokine therapy Procedure: antiangiogenesis therapy Procedure: antibody therapy Procedure: biological response modifier therapy Procedure: chemotherapy Procedure: growth factor antagonist therapy Procedure: monoclonal antibody therapy | Phase III |
MedlinePlus related topics: Colorectal Cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Adjuvant Chemotherapy Comprising Fluorouracil, Leucovorin Calcium, and Oxaliplatin With Versus Without Bevacizumab in Patients With Resected Stage II or III Adenocarcinoma of the Colon
OBJECTIVES: Primary
- Compare disease-free survival of patients with resected stage II or III adenocarcinoma of the colon treated with adjuvant chemotherapy comprising fluorouracil, leucovorin calcium, and oxaliplatin with vs without bevacizumab.
Secondary
- Compare overall survival of patients treated with these regimens.
Tertiary
- Determine the persistence of proteinuria after completion of bevacizumab in patients treated with bevacizumab.
- Correlate the development of proteinuria with clinical sequelae in patients treated with bevacizumab.
- Determine risk factors for development of proteinuria in patients treated with bevacizumab.
- Determine the effect of discontinuing bevacizumab on hypertension in these patients.
- Determine the incidence of delayed vascular events (e.g., myocardial infarction, CNS ischemia, and thrombosis) in patients treated with bevacizumab.
- Determine the effect of this drug on ovarian function in premenopausal women.
- Determine the incidence of immunogenicity and serum levels of bevacizumab in these patients.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center and number of positive lymph nodes (0 vs 1-3 vs > 3). Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive adjuvant chemotherapy comprising concurrent oxaliplatin and leucovorin calcium IV over 2 hours on day 1. Patients also receive adjuvant fluorouracil IV over 2-4 minutes on day 1 followed by fluorouracil IV continuously over 46 hours on days 1 and 2. Treatment repeats every 14 days for 12 courses in the absence of disease progression or unacceptable toxicity.
- Arm II: Patients receive bevacizumab IV over 30-90 minutes on day 1. Patients also receive adjuvant oxaliplatin, leucovorin calcium, and fluorouracil as in arm I. Treatment repeats every 14 days for 12 courses in the absence of disease progression or unacceptable toxicity. After completion of adjuvant chemotherapy, patients continue to receive bevacizumab alone every 14 days for 6 months in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
PROJECTED ACCRUAL: A total of 2,632 patients (1,316 per treatment arm) will be accrued for this study within 2.5 years.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed adenocarcinoma of the colon, meeting 1 of the following stage criteria:
- Stage II disease (T3 or 4, N0, M0)
- Stage III disease (any T, N1 or 2, M0)
- No rectal tumors
- Distal extent of tumor ≥ 12 cm from the anal verge by endoscopy or surgical examination
- T4 tumors involving an adjacent structure (e.g., bladder, small intestine, or ovary) by direct extension from the primary tumor are eligible provided the following criteria are met:
- All or a portion of the adjacent structure was removed with the primary tumor
- All grossly visible tumor was completely resected (i.e., curative resection) in the opinion of the surgeon
- Margins of the resected specimen not involved with malignant cells by pathology
- Not planning local radiotherapy
- complete gross resection of tumor by open laparotomy or laparoscopically-assisted colectomy within the past 29-50 days
- Two-stage surgical procedure allowed (i.e., decompressive colostomy followed by definitive surgical resection)
- Patients with > 1 synchronous primary colon tumor are eligible
- Disease staging based on more advanced primary tumor
- No isolated, distant, or non-contiguous intra-abdominal metastases, even if resected
PATIENT CHARACTERISTICS: Age
- 18 and over
Performance status
- ECOG 0-1
Life expectancy
- At least 5 years
Hematopoietic
- Absolute granulocyte count ≥ 1,500/mm^3 (unless it represents an ethnic or racial variation of normal)
- Platelet count ≥ 100,000/mm^3
- No significant bleeding unrelated to the primary colon tumor within the past 6 months
Hepatic
- Bilirubin normal (unless due to slow conjugation of bilirubin caused by Gilbert's disease or a similar syndrome)
- Alkaline phosphatase < 2.5 times upper limit of normal (ULN)
- AST < 1.5 times ULN
- No PT (INR) > 1.5 unless patient is on full-dose anticoagulants AND the following criteria are met:
- INR 2-3 on a stable dose of warfarin or low molecular weight heparin
- No active bleeding
- No pathological condition associated with a high risk of bleeding
- No hepatic disease that would preclude study participation
Renal
- Creatinine ≤ 1.5 times ULN
- Urine protein/creatinine ratio < 1.0 OR
- < 1 g of protein on 24-hour urine collection
- No renal disease that would preclude study participation
Cardiovascular
- No uncontrolled blood pressure, defined as > 150/90 mm Hg
- No prior CNS cerebrovascular ischemia
- No peripheral arterial ischemia within the past 6 months
- Brief, reversible, exercise-induced claudication allowed
- No visceral arterial ischemia within the past 6 months
- No cardiovascular disease that would preclude study participation, including any of the following:
- New York Heart Association class III or IV myocardial disease
- Myocardial infarction within the past 6 months
- Unstable angina within the past 6 months
- Current symptomatic arrhythmia
Other
- No other malignancy within the past 5 years except effectively treated squamous cell or basal cell skin cancer, melanoma in situ, carcinoma in situ of the cervix, or carcinoma
- of the colon or rectum
- Must be at low risk of recurrence from any prior malignancy
- No serious or non-healing wound, skin ulcer, or bone fracture
- No active gastroduodenal ulcer by endoscopy
- No clinically significant peripheral neuropathy (i.e., neurosensory or neuromotor toxicity ≥ grade 2)
- No significant traumatic injury within the past 4 weeks
- No other nonmalignant systemic disease that would preclude study participation
- No psychiatric or addictive disorder or other condition that would preclude study participation
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- Patients randomized to receive bevacizumab must use effective contraception during and for 3 months after study treatment
PRIOR CONCURRENT THERAPY: Biologic therapy
- No concurrent prophylactic growth factors
- No concurrent biological response modifiers
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- See Disease Characteristics
- No prior radiotherapy for this malignancy
- No concurrent radiotherapy for this malignancy
Surgery
- See Disease Characteristics
- Recovered from prior surgery
- More than 4 weeks since prior major surgery or open biopsy
- More than 7 days since prior core biopsy or other minor surgery (except placement of a vascular access device)
- No concurrent major surgery
Other
- No prior systemic therapy for this malignancy
- No concurrent halogenated antiviral agents (e.g., sorivudine)
- No other concurrent investigational drugs
- No other concurrent antineoplastic agents
Location and Contact Information
Alabama
Huntsville Hospital, Huntsville, Alabama, 35801, United States; Recruiting
Mobile Infirmary Medical Center, Mobile, Alabama, 36652-2144, United States; Recruiting
Arizona
CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States; Recruiting
Arkansas
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, 72903, United States; Recruiting
California
Bay Area Tumor Institute, Oakland, California, 94609, United States; Recruiting
Glendale Memorial Hospital and Health Center, Glendale, California, 91204, United States; Recruiting
Joliet Oncology Hematology Associates, Limited - East, La Jolla, California, 92037, United States; Recruiting
Kaiser Foundation Hospital - West Los Angeles, Los Angeles, California, 90034, United States; Recruiting
Kaiser Permanente Medical Center - Hayward, Hayward, California, 94545, United States; Recruiting
Kaiser Permanente Medical Center - Redwood City, Redwood City, California, 94063, United States; Recruiting
Kaiser Permanente Medical Center - Roseville, Roseville, California, 95661, United States; Recruiting
Kaiser Permanente Medical Center - Sacramento, Sacramento, California, 95825, United States; Recruiting
Kaiser Permanente Medical Center - San Francisco French Campus, San Francisco, California, 94118, United States; Recruiting
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, 95051-5386, United States; Recruiting
Kaiser Permanente Medical Center - Santa Rosa, Santa Rosa, California, 95403, United States; Recruiting
Kaiser Permanente Medical Center - Santa Teresa, Santa Teresa, California, 95119, United States; Recruiting
Kaiser Permanente Medical Center - South San Francisco, South San Francisco, California, 94080, United States; Recruiting
Kaiser Permanente Medical Group, Panorama City, California, 91402, United States; Recruiting
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, 92354, United States; Recruiting
North Bay Cancer Center, Fairfield, California, 94533, United States; Recruiting
Permanente Medical Group, San Jose, California, 95119, United States; Recruiting
Providence Saint Joseph Medical Center - Burbank, Burbank, California, 91505, United States; Recruiting
Santa Rosa Memorial Hospital, Santa Rosa, California, 95405, United States; Recruiting
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, 94305, United States; Recruiting
Sutter Cancer Center, Sacramento, California, 95816, United States; Recruiting
Sutter Roseville Medical Center, Roseville, California, 95661, United States; Recruiting
Veterans Affairs Medical Center - Loma Linda (Pettis), Loma Linda, California, 92357, United States; Recruiting
Colorado
Boulder Community Hospital, Boulder, Colorado, 80301-9019, United States; Recruiting
CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, 80224, United States; Recruiting
Exempla Lutheran Medical Center, Wheat Ridge, Colorado, 80033, United States; Recruiting
Front Range Cancer Specialists, Fort Collins, Colorado, 80524-4038, United States; Recruiting
McKee Medical Center, Loveland, Colorado, 80538, United States; Recruiting
Medical Center of Aurora - South Campus, Aurora, Colorado, 80012-0000, United States; Recruiting
North Suburban Medical Center, Thornton, Colorado, 80229, United States; Recruiting
Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, 80933, United States; Recruiting
Poudre Valley Hospital, Fort Collins, Colorado, 80524, United States; Recruiting
Presbyterian - St. Luke's Medical Center, Denver, Colorado, 80218, United States; Recruiting
Rose Medical Center, Denver, Colorado, 80220, United States; Recruiting
Sky Ridge Medical Center, Lone Tree, Colorado, 80124, United States; Recruiting
St. Mary-Corwin Regional Medical Center, Pueblo, Colorado, 81004, United States; Recruiting
Swedish Medical Center, Englewood, Colorado, 80113, United States; Recruiting
Connecticut
Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, 06360-2875, United States; Recruiting
New Britain General Hospital, New Britain, Connecticut, 06050, United States; Recruiting
Delaware
Beebe Medical Center, Lewes, Delaware, 19958, United States; Recruiting
Helen F. Graham Cancer Center, Wilmington, Delaware, 19809, United States; Recruiting
Nanticoke Memorial Hospital, Seaford, Delaware, 19973, United States; Recruiting
St. Francis Hospital, Wilmington, Delaware, 19805, United States; Recruiting
District of Columbia
Sibley Memorial Hospital, Washington, District of Columbia, 20016, United States; Recruiting
Florida
Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, 32207, United States; Recruiting
CCOP - Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States; Recruiting
Ella Milbank Foshay Cancer Center at Jupiter Medical Center, Jupiter, Florida, 33458, United States; Recruiting
Halifax Medical Center, Daytona Beach, Florida, 32114, United States; Recruiting
Joe DiMaggio Children's Hospital at Memorial, Hollywood, Florida, 33021, United States; Recruiting
Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States; Recruiting
Georgia
Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, 30033, United States; Recruiting
Northside Hospital Cancer Center, Atlanta, Georgia, 30342-1611, United States; Recruiting
Phoebe Cancer Center at Phoebe Putney Memorial Hospital, Albany, Georgia, 31701, United States; Recruiting
Piedmont Hospital, Atlanta, Georgia, 30309, United States; Recruiting
Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, 30342-1701, United States; Recruiting
Southern Regional Medical Center, Riverdale, Georgia, 30274-2600, United States; Recruiting
WellStar Cobb Hospital, Austell, Georgia, 30106, United States; Recruiting
Wellstar Kennestone Hospital, Marietta, Georgia, 30060, United States; Recruiting
Hawaii
Kapiolani Medical Center at Pali Momi, Aiea, Hawaii, 96701, United States; Recruiting
OnCare Hawaii, Incorporated - Kuakini, Honolulu, Hawaii, 96817, United States; Recruiting
OnCare Hawaii, Incorporated - Lusitana, Honolulu, Hawaii, 96813, United States; Recruiting
Queen's Cancer Institute at Queen's Medical Center, Honolulu, Hawaii, 96813, United States; Recruiting
St. Francis Medical Center, Honolulu, Hawaii, 96817, United States; Recruiting
Straub Clinic and Hospital, Incorporated, Honolulu, Hawaii, 96813, United States; Recruiting
University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, 96822, United States; Recruiting
Idaho
North Idaho Cancer Center, Coeur D Alene, Idaho, 83814, United States; Recruiting
Illinois
Alexian Brothers Cancer Care Center, Elk Grove Village, Illinois, 60007, United States; Recruiting
Carle Clinic Association, Urbana, Illinois, 61801, United States; Recruiting
CCOP - Carle Cancer Center, Urbana, Illinois, 61801, United States; Recruiting
Ingalls Cancer Care Center at Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States; Recruiting
Rush-Copley Cancer Care Center, Aurora, Illinois, 60504-4206, United States; Recruiting
Saint Anthony's Hospital at Saint Anthony's Health Center, Alton, Illinois, 62002, United States; Recruiting
St. Mary's Hospital, Decatur, Illinois, 62521, United States; Recruiting
Swedish American Hospital, Rockford, Illinois, 61104, United States; Recruiting
Swedish-American Regional Cancer Center, Rockford, Illinois, 61104-2315, United States; Recruiting
Trinity Medical Center - East, Moline, Illinois, 61265-1291, United States; Recruiting
West Suburban Center for Cancer Care, River Forest, Illinois, 60305, United States; Recruiting
Indiana
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, 46601, United States; Recruiting
Center for Cancer Care at Goshen Health System, Goshen, Indiana, 46526, United States; Recruiting
Center for Cancer Therapy at LaPorte Hospital and Health Services, LaPorte, Indiana, 46350-0250, United States; Recruiting
Community Hospital, Munster, Indiana, 46321, United States; Recruiting
Elkhart General Hospital, Elkhart, Indiana, 46514-1329, United States; Recruiting
Elliot Regional Cancer Center, Elkhart, Indiana, 46514-1329, United States; Recruiting
Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States; Recruiting
Porter Memorial Hospital, Valparaiso, Indiana, 46383, United States; Recruiting
Saint Anthony Memorial Health Centers, Michigan City, Indiana, 46360-4358, United States; Recruiting
St. Francis Hospital and Health Centers, Beech Grove, Indiana, 46107, United States; Recruiting
Iowa
Cancer Center at Ottumwa Regional Health Center, Ottumwa, Iowa, 52501, United States; Recruiting
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, 50309-1016, United States; Recruiting
Cedar Valley Medical Specialists, P.C. - West Ridgeway Avenue, Waterloo, Iowa, 50701, United States; Recruiting
Covenant Medical Center, Waterloo, Iowa, 50702, United States; Recruiting
Genesis Medical Center - West Campus, Davenport, Iowa, 52804, United States; Recruiting
Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, 52803, United States; Recruiting
Iowa Blood and Cancer Care, Cedar Rapids, Iowa, 52402-5057, United States; Recruiting
Iowa Clinic - Iowa Methodist Campus, Des Moines, Iowa, 50309, United States; Recruiting
John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, 50316-2301, United States; Recruiting
McFarland Clinic, P.C., Ames, Iowa, 50010, United States; Recruiting
Medical Oncology and Hematology Associates - West Des Moines, West Des Moines, Iowa, 50266, United States; Recruiting
Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, 50309, United States; Recruiting
Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, 50314, United States; Recruiting
Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States; Recruiting
Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, 50401, United States; Recruiting
Mercy Hospital, Iowa City, Iowa, 52245, United States; Recruiting
St. Luke's Hospital, Cedar Rapids, Iowa, 52406, United States; Recruiting
Kansas
Cancer Center at Stormont-Vail Regional Health Center, Topeka, Kansas, 66606, United States; Recruiting
Cancer Center of Kansas, P.A. - El Dorado, El Dorado, Kansas, 67042, United States; Recruiting
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States; Recruiting
Mount Carmel Regional Cancer Center, Pittsburg, Kansas, 66762, United States; Recruiting
St. Francis Comprehensive Cancer Center, Topeka, Kansas, 66606, United States; Recruiting
Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, 67214, United States; Recruiting
Kentucky
Baptist Hospital East - Louisville, Louisville, Kentucky, 40207, United States; Recruiting
Louisiana
CCOP - Ochsner, New Orleans, Louisiana, 70121, United States; Recruiting
Ochsner Cancer Institute at Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States; Recruiting
Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans, Louisiana, 70112-2699, United States; Recruiting
Maine
York Hospital, York, Maine, 03909-1099, United States; Recruiting
Maryland
Frederick Memorial Hospital Regional Cancer Therapy Center, Frederick, Maryland, 21701, United States; Recruiting
Greater Baltimore Colorectal Specialists, Baltimore, Maryland, 21204, United States; Recruiting
Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center, Baltimore, Maryland, 21237, United States; Recruiting
St. Mary's Hospital, Leonardtown, Maryland, 20650, United States; Recruiting
Suburban Hospital, Bethesda, Maryland, 20814, United States; Recruiting
Union Hospital Cancer Center at Union Hospital, Elkton, Maryland, 21921, United States; Recruiting
Massachusetts
Berkshire Medical Center, Pittsfield, Massachusetts, 01201, United States; Recruiting
Cancer Research Center at Boston Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Hudner Oncology Center at Saint Anne's Hospital, Fall River, Massachusetts, 02721, United States; Recruiting
Jordan Hospital Club Cancer Center, Plymouth, Massachusetts, 02360, United States; Recruiting
Lahey Clinic Medical Center - Burlington, Burlington, Massachusetts, 01805, United States; Recruiting
Michigan
Battle Creek Health System, Battle Creek, Michigan, 49016, United States; Recruiting
Borgess Medical Center, Kalamazoo, Michigan, 49048-1666, United States; Recruiting
Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States; Recruiting
Grand Rapids Clinical Oncology, Grand Rapids, Michigan, 49503, United States; Recruiting
Henry Ford Wyandotte Hospital, Wyandotte, Michigan, 48192, United States; Recruiting
Holland Community Hospital, Holland, Michigan, 49423, United States; Recruiting
Lacks Cancer Center at Saint Mary's Mercy Medical Center, Grand Rapids, Michigan, 49503, United States; Recruiting
Mecosta County General Hospital, Big Rapids, Michigan, 49307, United States; Recruiting
Mercy Memorial Hospital System, Monroe, Michigan, 48162, United States; Recruiting
Metropolitan Hospital, Grand Rapids, Michigan, 49506, United States; Recruiting
Munson Medical Center, Traverse City, Michigan, 49684, United States; Recruiting
Northern Michigan Hospital, Petoskey, Michigan, 49770, United States; Recruiting
Spectrum Health Cancer Care - Butterworth Campus, Grand Rapids, Michigan, 49503, United States; Recruiting
Spectrum Health Hospital - Blodgett Campus, Grand Rapids, Michigan, 49506, United States; Recruiting
West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States; Recruiting
Minnesota
Cancer Care Center at Regions Hospital, Saint Paul, Minnesota, 55101, United States; Recruiting
Cancer Care Center at St. Luke's Hospital, Duluth, Minnesota, 55802, United States; Recruiting
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, 55416, United States; Recruiting
Duluth Clinic - Hibbing, Hibbing, Minnesota, 55746, United States; Recruiting
Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States; Recruiting
Fairview Southdale Hospital, Edina, Minnesota, 55435, United States; Recruiting
Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, 55415, United States; Recruiting
Hubert H. Humphrey Cancer Center at North Memorial Medical Center - Coon Rapids, Coon Rapids, Minnesota, 55433, United States; Recruiting
Hutchinson Area Health Care, Hutchinson, Minnesota, 55350, United States; Recruiting
Meeker County Memorial Hospital, Lichfield, Minnesota, 55355, United States; Recruiting
Mercy and Unity Cancer Center at Mercy and Unity Hospitals, Fridley, Minnesota, 55432-2799, United States; Recruiting
Mercy Hospital, Coon Rapids, Minnesota, 55433, United States; Recruiting
Merit Care Clinic - Bemidji, Bemidji, Minnesota, 56601, United States; Recruiting
Miller-Dwan Medical Center, Duluth, Minnesota, 55805, United States; Recruiting
Park Nicollet Clinic, St. Louis Park, Minnesota, 55416, United States; Recruiting
Ridgeview Medical Center, Waconia, Minnesota, 55387, United States; Recruiting
Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States; Recruiting
St. John's Hospital, Maplewood, Minnesota, 55109, United States; Recruiting
St. Joseph's Hospital, Saint Paul, Minnesota, 55102, United States; Recruiting
United Hospital, Saint Paul, Minnesota, 55102, United States; Recruiting
Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States; Recruiting
Mississippi
Hattiesburg Clinic, P.A., Hattiesburg, Mississippi, 39401, United States; Recruiting
Hematology & Oncology Clinic, Hattiesburg, Mississippi, 39402, United States; Recruiting
Missouri
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States; Recruiting
CCOP - Kansas City, Kansas City, Missouri, 64131, United States; Recruiting
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States; Recruiting
David C. Pratt Cancer Center at St. John's Mercy, Saint Louis, Missouri, 63141, United States; Recruiting
Freeman Cancer Institute at Freeman Health System, Joplin, Missouri, 64804, United States; Recruiting
Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, 65807, United States; Recruiting
Saint Joseph Hospital, Saint Louis, Missouri, 63122, United States; Recruiting
Saint Luke's Hospital, Chesterfield, Missouri, 63017, United States; Recruiting
Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital, Cape Girardeau, Missouri, 63701, United States; Recruiting
St. John's Regional Medical Center, Joplin, Missouri, 64804, United States; Recruiting
Montana
Big Sky Oncology, Great Falls, Montana, 59405, United States; Recruiting
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States; Recruiting
Nebraska
Bryan LGH Medical Center - East, Lincoln, Nebraska, 68506, United States; Recruiting
Bryan LGH Medical Center West, Lincoln, Nebraska, 68502-3780, United States; Recruiting
St. Elizabeth Regional Medical Center, Lincoln, Nebraska, 68510, United States; Recruiting
Nevada
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States; Recruiting
University of Nevada School of Medicine, Reno, Nevada, 89557-0046, United States; Recruiting
New Jersey
Cooper Cancer Institute at Cooper University Hospital, Voorhees, New Jersey, 08043, United States; Recruiting
Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States; Recruiting
South Jersey Hospital System - Elmer, Elmer, New Jersey, 08318, United States; Recruiting
Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, 07201, United States; Recruiting
New Mexico
Hematology-Oncology Associates, PC, Albuquerque, New Mexico, 87106, United States; Recruiting
Lovelace Medical Center at Lovelace Sandia Health System, Albuquerque, New Mexico, 87108, United States; Recruiting
New Mexico Cancer Care Associates, Santa Fe, New Mexico, 87505-7670, United States; Recruiting
University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, 87131-5636, United States; Recruiting
New York
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., East Syracuse, New York, 13057, United States; Recruiting
Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls, New York, 12801, United States; Recruiting
North Carolina
Rutherford Hospital, Rutherfordton, North Carolina, 28139-0000, United States; Recruiting
North Dakota
Bismarck Cancer Center, Bismarck, North Dakota, 58501-4445, United States; Recruiting
Medcenter One Health System, Bismarck, North Dakota, 58501, United States; Recruiting
MeritCare Medical Group, Fargo, North Dakota, 58103-2067, United States; Recruiting
Meritcare Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States; Recruiting
Mid Dakota Clinic, P.C., Bismarck, North Dakota, 58501, United States; Recruiting
St. Alexius Medical Center, Bismarck, North Dakota, 58502, United States; Recruiting
Ohio
Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, 43055-2899, United States; Recruiting
Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States; Recruiting
Akron City Hospital at Summa Health System, Akron, Ohio, 44309-2090, United States; Recruiting
Akron General's McDowell Cancer Center, Akron, Ohio, 44302, United States; Recruiting
Aultman Hospital Cancer Center at Aultman Health Foundation, Canton, Ohio, 44710-1799, United States; Recruiting
CCOP - Columbus, Columbus, Ohio, 43206, United States; Recruiting
CCOP - Dayton, Dayton, Ohio, 45429, United States; Recruiting
Community Hospital of Springfield and Clark County, Springfield, Ohio, 45505, United States; Recruiting
Doctors Hospital at Ohio Health, Columbus, Ohio, 43228, United States; Recruiting
Fairfield Medical Center, Lancaster, Ohio, 43130, United States; Recruiting
Good Samaritan Hospital, Dayton, Ohio, 45406-1891, United States; Recruiting
Grady Memorial Hospital, Delaware, Ohio, 43015, United States; Recruiting
Grandview Hospital, Dayton, Ohio, 45405, United States; Recruiting
MedCentral - Mansfield Hospital, Mansfield, Ohio, 44903, United States; Recruiting
Miami Valley Hospital, Dayton, Ohio, 45409, United States; Recruiting
Middletown Regional Hospital, Middletown, Ohio, 45044-4898, United States; Recruiting
Mount Carmel West Hospital, Columbus, Ohio, 43222, United States; Recruiting
Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, 45385, United States; Recruiting
Samaritan North Cancer Care Center, Dayton, Ohio, 45415, United States; Recruiting
Strecker Cancer Center at Marietta Memorial Hospital, Marietta, Ohio, 45750-1635, United States; Recruiting
University Hospitals Ireland Cancer Center at Mercy Medical Center, Canton, Ohio, 44708, United States; Recruiting
Oklahoma
LaFortune Cancer Center at St. John Health System, Tulsa, Oklahoma, 74104, United States; Recruiting
Oregon
Bend Memorial Clinic, Bend, Oregon, 97701-6099, United States; Recruiting
Comprehensive Cancer Center at Legacy Good Samaritan Hospital & Medical Center, Portland, Oregon, 97210, United States; Recruiting
Legacy Emanuel Hospital and Health Center & Children's Hospital, Portland, Oregon, 97227, United States; Recruiting
Legacy Meridian Park Hospital, Tualatin, Oregon, 97062, United States; Recruiting
Legacy Mount Hood Medical Center, Gresham, Oregon, 97030, United States; Recruiting
Providence Cancer Center at Providence Portland Medical Center, Portland, Oregon, 97213-2967, United States; Recruiting
Providence Milwaukie Hospital, Milwaukie, Oregon, 97222-6593, United States; Recruiting
Providence St. Vincent Medical Center, Portland, Oregon, 97225, United States; Recruiting
St. Charles Medical Center, Bend, Oregon, 97701, United States; Recruiting
Pennsylvania
Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, 19010, United States; Recruiting
Cancer Center at Paoli Memorial Hospital, Paoli, Pennsylvania, 19301-1792, United States; Recruiting
CCOP - MainLine Health, Wynnewood, Pennsylvania, 19096, United States; Recruiting
Central Pennsylvania Hematology and Medical Oncology Associates, PC, Lemoyne, Pennsylvania, 17043-1440, United States; Recruiting
Ephrata Cancer Center at Ephrata Community Hospital, Ephrata, Pennsylvania, 17522-1002, United States; Recruiting
Geisinger Medical Center, Danville, Pennsylvania, 17822-2001, United States; Recruiting
Geisinger Medical Group, State College, Pennsylvania, 16801, United States; Recruiting
Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania, 18711, United States; Recruiting
Guthrie Medical Center - Sayre, Sayre, Pennsylvania, 18840, United States; Recruiting
Hematology-Oncology Association of Northeastern Pennsylvania, Dunmore, Pennsylvania, 18512, United States; Recruiting
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, 19107-5541, United States; Recruiting
Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania, 19096, Un
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: March 2005
Last Updated: April 5, 2005
Record first received: November 9, 2004
ClinicalTrials.gov Identifier: NCT00096278
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -